Ibudilast plus interferon-beta to get European patent for progressive MS
MediciNova announced the approval of a European patent covering the use of ibudilast (MN-166) in combination with interferon-beta medications to treat progressive forms of multiple sclerosis (MS) ā primary progressive MS (PPMS) and secondary progressive MS (SPMS) ā in patients previously using an interferon-beta.